Biotechnology
10 Amgen business development leaders
These ten current and former Amgen business development leaders have held director, executive director and head roles in business development, licensing, transactions, search and evaluation and alliance management at Amgen. A reader can learn how business development leaders work at Amgen from people who have held the role.
Professionals to explore
01—10Alex Turner
LinkedInExperience: Head, External R&D, Rare Disease · Amgen
Former Head, External R&D, Rare Disease at Amgen (2025–2026), after serving as Executive Director, External R&D, Rare Disease and, earlier, Licensing Director at Amgen (2012–2018). His profile says he headed search and evaluation in inflammation, metabolism, bone and nephrology. He is now Executive Director, Search and Evaluation at Kardigan.
Amanda Rose Mason
LinkedInExperience: Executive Director, Business Development · Amgen
Executive Director, Business Development at Amgen since September 2024; her profile describes serving as global head of search and evaluation for Amgen's obesity and general medicines franchises, responsible for deals from strategy through due diligence. She was earlier Director and Senior Manager in Amgen business development.
Erin Denny
LinkedInExperience: Executive Director Oncology Business Development · Amgen
Executive Director Oncology Business Development at Amgen since September 2023, with a headline that also covers inflammation. She was Director Oncology Business Development (2021–2023) and earlier held licensing manager and senior manager roles in Amgen oncology business development from 2017.
Erin Gibson
LinkedInExperience: Director, Business Development - Alliance Management · Amgen
Director, Business Development - Alliance Management at Amgen since April 2024; her profile describes serving as global partnership lead and alliance manager for a portfolio of late-stage development and commercial alliances. She was earlier Senior Manager (2020–2024) and Manager (2017–2020) in Amgen business development alliance management, after operations and transactions associate roles in Amgen business development (2013–2017).
Helen Y. Kim
LinkedInExperience: Executive Director & Head of Technology, Business Development · Amgen
Executive Director & Head of Technology, Business Development at Amgen since March 2021; her profile describes leading a team that identifies and evaluates technologies that enable drug discovery, including immuno-oncology and small and large molecule platforms. She was earlier Director, Research at Amgen (2010–2021).
Nikita Jaipuria
LinkedInExperience: Director, Transactions, Business Development · Amgen
Director, Transactions, Business Development at Amgen since June 2025, after serving as Senior Manager, Transactions (2020–2025) and in valuations within Amgen business development. Her profile describes leading the full deal lifecycle across asset stages and deal types and heading global out-licensing activities.
Norbert Prenzel
LinkedInExperience: Licensing Director · Amgen
Former Licensing Director at Amgen (2012–2015), based at Amgen Research Munich, after serving as Director Business Development at Micromet AG. He has been Head of Business Development and Licensing at SOTIO Biotech since 2015, and earlier co-founded U3 Pharma GmbH, where he managed business development.
Olaf Koenig
LinkedInExperience: Executive Director, International Business Development · Amgen
Executive Director, International Business Development at Amgen since May 2019, based in Zug, Switzerland, after serving as Director International Business Development and Director Business Development Europe at Amgen. He was earlier Vice President Business Development and New Product Planning at Daiichi Sankyo (2002–2016).
Sahaj Madhav
LinkedInExperience: Head of Transactions (Interim) Executive Director · Amgen
Interim Head of Transactions and Executive Director at Amgen since November 2025, after serving as Executive Director Business Development (2023–2025) and Director Of Business Development (2021–2023). The profile describes leading or supporting transactions including M&A, spin-outs, out-licenses, equity investments, product acquisitions and collaborations.
Tracy M. Blois
LinkedInExperience: Head of Alliance Management · Amgen
Head of Alliance Management at Amgen since December 2022; she also served at Amgen as Executive Director, Business Transformation (2022–2023) and Director of Strategic Planning & Operations Global Marketing, Access, and Capabilities (2020–2022). She was earlier Director, Alliance Management (2017–2020); her profile describes a career spanning business development and alliance management.
Choose the right perspective
Match the person's scope to your question, since search and evaluation, deal transactions, technology partnerships, international business development and alliance management involve different work. Check whether the person's role is current or former and which therapeutic area it covers, since both shape what they can speak to.
Questions to take into the conversation
- 01How does a large biotechnology company run search and evaluation by franchise?
- 02How are transaction teams staffed from first term sheet to deal close?
- 03How does alliance management govern late-stage development and commercial partnerships?
Reaching Amgen business development leaders
How can I contact one of these Amgen business development leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Amgen, based on profile data retrieved on October 9, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Amgen business development leaders?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Amgen business development leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal